Natalya M. Kogan

1.3k total citations
27 papers, 974 citations indexed

About

Natalya M. Kogan is a scholar working on Pharmacology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Natalya M. Kogan has authored 27 papers receiving a total of 974 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 8 papers in Molecular Biology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Natalya M. Kogan's work include Cannabis and Cannabinoid Research (15 papers), Diet, Metabolism, and Disease (5 papers) and Cancer therapeutics and mechanisms (3 papers). Natalya M. Kogan is often cited by papers focused on Cannabis and Cannabinoid Research (15 papers), Diet, Metabolism, and Disease (5 papers) and Cancer therapeutics and mechanisms (3 papers). Natalya M. Kogan collaborates with scholars based in Israel, United States and United Kingdom. Natalya M. Kogan's co-authors include Raphael Mechoulam, Pál Pacher, Michael Schlesinger, Maximilian Peters, Ruth Rabinowitz, Arieh Moussaieff, Daniel Aberdam, Péter Sándor, Dan Gibson and Cristina Blázquez and has published in prestigious journals such as Proceedings of the National Academy of Sciences, American Journal of Clinical Nutrition and Journal of Cell Science.

In The Last Decade

Natalya M. Kogan

27 papers receiving 951 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Natalya M. Kogan Israel 15 650 235 202 131 115 27 974
Mariateresa Cipriano Sweden 16 867 1.3× 278 1.2× 261 1.3× 129 1.0× 166 1.4× 25 1.3k
Kent‐Olov Jonsson Sweden 10 625 1.0× 137 0.6× 211 1.0× 109 0.8× 118 1.0× 10 743
Roberta Verde Italy 22 771 1.2× 302 1.3× 233 1.2× 145 1.1× 161 1.4× 41 1.4k
Daniele Bolognini United Kingdom 21 813 1.3× 586 2.5× 537 2.7× 181 1.4× 130 1.1× 29 1.5k
Randy J. Krebsbach United States 16 1.2k 1.9× 181 0.8× 390 1.9× 148 1.1× 187 1.6× 18 1.5k
Matthew W. Elmes United States 10 438 0.7× 175 0.7× 187 0.9× 64 0.5× 88 0.8× 13 676
Mai Hazekawa Japan 15 367 0.6× 225 1.0× 173 0.9× 80 0.6× 65 0.6× 47 931
Andrei Sibaev Germany 17 996 1.5× 300 1.3× 290 1.4× 144 1.1× 286 2.5× 37 1.7k
Thomas F. Gamage United States 17 639 1.0× 254 1.1× 491 2.4× 51 0.4× 44 0.4× 33 917
Nathalie Niederhoffer France 18 470 0.7× 199 0.8× 214 1.1× 26 0.2× 80 0.7× 33 1.1k

Countries citing papers authored by Natalya M. Kogan

Since Specialization
Citations

This map shows the geographic impact of Natalya M. Kogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalya M. Kogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalya M. Kogan more than expected).

Fields of papers citing papers by Natalya M. Kogan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalya M. Kogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalya M. Kogan. The network helps show where Natalya M. Kogan may publish in the future.

Co-authorship network of co-authors of Natalya M. Kogan

This figure shows the co-authorship network connecting the top 25 collaborators of Natalya M. Kogan. A scholar is included among the top collaborators of Natalya M. Kogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalya M. Kogan. Natalya M. Kogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kogan, Natalya M., et al.. (2025). Differential metabolic pathways underlie THC- and CBD-mediated inhibition of B-cell activation in both young and aged mice. Frontiers in Immunology. 16. 1605474–1605474. 1 indexed citations
2.
Sionov, Ronit Vogt, et al.. (2024). Antifungal properties of abnormal cannabinoid derivatives: Disruption of biofilm formation and gene expression in Candida species. Pharmacological Research. 209. 107441–107441. 1 indexed citations
3.
Koman, Igor, et al.. (2024). Targeted Glioma Therapy—Clinical Trials and Future Directions. Pharmaceutics. 16(1). 100–100. 13 indexed citations
4.
Mechoulam, Raphael, et al.. (2023). Cannabinoid Receptor 2 Blockade Prevents Anti-Depressive-like Effect of Cannabidiol Acid Methyl Ester in Female WKY Rats. International Journal of Molecular Sciences. 24(4). 3828–3828. 7 indexed citations
5.
Kogan, Natalya M., Sergey Malitsky, Maxim Itkin, et al.. (2023). Endocannabinoid basis of personality—Insights from animal model of social behavior. Frontiers in Pharmacology. 14. 1234332–1234332. 2 indexed citations
6.
Kogan, Natalya M., Richard Williams, Fiona E. McCann, et al.. (2021). Novel CBG Derivatives Can Reduce Inflammation, Pain and Obesity. Molecules. 26(18). 5601–5601. 20 indexed citations
7.
Kogan, Natalya M., Maximilian Peters, & Raphael Mechoulam. (2021). Cannabinoid Quinones—A Review and Novel Observations. Molecules. 26(6). 1761–1761. 26 indexed citations
8.
Saidemberg, Daniel M., Natalya M. Kogan, Nir Goldstein, et al.. (2020). Distinct infrastructure of lipid networks in visceral and subcutaneous adipose tissues in overweight humans. American Journal of Clinical Nutrition. 112(4). 979–990. 11 indexed citations
9.
Batushansky, Albert, et al.. (2020). A Shift in Glycerolipid Metabolism Defines the Follicular Fluid of IVF Patients with Unexplained Infertility. Biomolecules. 10(8). 1135–1135. 12 indexed citations
10.
Pacher, Pál, Natalya M. Kogan, & Raphael Mechoulam. (2019). Beyond THC and Endocannabinoids. The Annual Review of Pharmacology and Toxicology. 60(1). 637–659. 112 indexed citations
11.
Kogan, Natalya M., Eitan Melamed, Aviva Breuer, et al.. (2015). Cannabidiol, a Major Non-Psychotropic Cannabis Constituent Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts. Journal of Bone and Mineral Research. 30(10). 1905–1913. 78 indexed citations
12.
Sumariwalla, Percy F., et al.. (2015). HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid. Journal of Pharmacology and Experimental Therapeutics. 355(1). 66–75. 19 indexed citations
13.
Smoum, Reem, Saja Baraghithy, Mukesh Chourasia, et al.. (2015). CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency. Proceedings of the National Academy of Sciences. 112(28). 8774–8779. 54 indexed citations
14.
Moussaieff, Arieh, Natalya M. Kogan, & Daniel Aberdam. (2015). Concise Review: Energy Metabolites: Key Mediators of the Epigenetic State of Pluripotency. Stem Cells. 33(8). 2374–2380. 40 indexed citations
15.
Ben‐Gedalya, Tziona, Roman Lyakhovetsky, Michal Bejerano‐Sagie, et al.. (2011). Cyclosporin-A-induced prion protein aggresomes are dynamic quality-control cellular compartments. Journal of Cell Science. 124(11). 1891–1902. 30 indexed citations
16.
Peters, Maximilian & Natalya M. Kogan. (2007). HU-331: a cannabinoid quinone, with uncommon cytotoxic properties and low toxicity. Expert Opinion on Investigational Drugs. 16(9). 1405–1413. 14 indexed citations
17.
Kogan, Natalya M., et al.. (2007). A Cannabinoid Anticancer Quinone, HU-331, Is More Potent and Less Cardiotoxic Than Doxorubicin: A Comparative in Vivo Study. Journal of Pharmacology and Experimental Therapeutics. 322(2). 646–653. 37 indexed citations
18.
Kogan, Natalya M., Cristina Blázquez, Luis Álvarez, et al.. (2006). A Cannabinoid Quinone Inhibits Angiogenesis by Targeting Vascular Endothelial Cells. Molecular Pharmacology. 70(1). 51–59. 61 indexed citations
19.
Kogan, Natalya M. & Raphael Mechoulam. (2006). The chemistry of endocannabinoids.. PubMed. 29(3 Suppl). 3–14. 60 indexed citations
20.
Kogan, Natalya M.. (2005). Cannabinoids and Cancer. Mini-Reviews in Medicinal Chemistry. 5(10). 941–952. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mariateresa Cipriano Breakdown of academic impact, for papers by Kent‐Olov Jonsson Breakdown of academic impact, for papers by Roberta Verde Breakdown of academic impact, for papers by Daniele Bolognini Breakdown of academic impact, for papers by Randy J. Krebsbach Breakdown of academic impact, for papers by Matthew W. Elmes Breakdown of academic impact, for papers by Mai Hazekawa Breakdown of academic impact, for papers by Andrei Sibaev Breakdown of academic impact, for papers by Thomas F. Gamage Breakdown of academic impact, for papers by Nathalie Niederhoffer
Rankless by CCL
2026